DRibbles efficiently cross-prime antigen-specific naïve CD8+ and CD4+ T cells; and DRibbles vaccine induce an anti-tumor efficacy in different tumor models such as melanomas, lung carcinomas and breast carcinomas [11,13,20]. This evidence concerns the gene CD4 and breast carcinoma.